Which medications in the drug class Bradykinin Receptor Antagonists are used in the treatment of Acquired Angioedema Due to C1 Inhibitor Deficiency?

Updated: May 20, 2020
  • Author: Amanda T Moon, MD; Chief Editor: William D James, MD  more...
  • Print
Answer

Bradykinin Receptor Antagonists

Bradykinin receptor antagonists such as icatibant inhibit bradykinin from binding the B2 receptor and thereby treat the clinical symptoms of an acute attack. Recommended dose of icatibant is 30 mg SC in the abdominal area. It is available as a single-use, prefilled syringe, which delivers a dose of 30 mg (10 mg/mL).

Icatibant (Firazyr)

Icatibant is a bradykinin B2 receptor antagonist indicated for acute attacks of hereditary angioedema (HAE).


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!